Lewis H. Bender

Lew Bender Intensity Therapeutics

Bender earned degrees in Chemical Engineering from MIT, an MA in International Studies from UPenn and an MBA from UPenn’s Wharton School of Business. He is the former CEO of Interleukin Genetics, a personalized medicine company, and held various roles from business development and manufacturing to CTO and CEO of Emisphere Technologies, a drug delivery company.  Read more about Lewis H. Bender